Definium Therapeutics DFTX
NASDAQ DFTX
$38.41 +2.24 (+6.19%)
At close: Sep 28, 2026 · 4:00 PM EDT

Definium Therapeutics (DFTX) Total Current Liabilities (2020 - 2026)

Updated

Definium Therapeutics (DFTX) recorded Total Current Liabilities of $157.2 million in Q2 2026, up 314.2% from $37.96 million a year earlier and up 93.8% from the prior quarter.

Analysis

Definium Therapeutics (DFTX) Total Current Liabilities (2020 - 2026) Analysis & Trends

At the end of FY2025, Definium Therapeutics reported Total Current Liabilities of $66.7 million, up 71.7% from FY2024.

  • Annual Total Current Liabilities has increased for five straight years, with a five-year compound annual growth rate of 85.9% (FY2020 to FY2025).
  • Across earlier years, Total Current Liabilities came in at $38.85 million in FY2024 (+20.5%), $32.25 million in FY2023 (+80.2%), $17.89 million in FY2022 (+71.9%) and $10.41 million in FY2021 (+246.0%).
  • The Q2 2026 figure is the highest quarterly Total Current Liabilities in data going back to Q4 2020.
  • On a year-over-year basis, Total Current Liabilities has increased for four consecutive quarters, with growth averaging 76.7% over the last eight quarters.
  • Peak year-over-year performance for Total Current Liabilities in the last five years was growth of 346.2% in Q2 2023, against a decline of 53.3% in Q1 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $81.11 million (Q1 2026), $66.7 million (Q4 2025) and $65.42 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 54.90 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 41.64 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn -31.55 Bn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 3.94 Bn
10 Definium Therapeutics 4.00 Bn 4.00 Bn - 157.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 157.20 Mn
Mar 31, 2026 81.11 Mn
Dec 31, 2025 66.70 Mn
Sep 30, 2025 65.42 Mn
Jun 30, 2025 37.96 Mn
Mar 31, 2025 30.48 Mn
Dec 31, 2024 38.85 Mn
Sep 30, 2024 33.27 Mn
Jun 30, 2024 41.85 Mn
Mar 31, 2024 65.27 Mn
Dec 31, 2023 32.25 Mn
Sep 30, 2023 31.15 Mn
Jun 30, 2023 35.12 Mn
Mar 31, 2023 24.10 Mn
Dec 31, 2022 17.89 Mn
Sep 30, 2022 26.04 Mn
Jun 30, 2022 7.87 Mn
Mar 31, 2022 10.56 Mn
Dec 31, 2021 10.41 Mn
Dec 31, 2020 3.01 Mn
API Access

Definium Therapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=DFTX&period=max&api_key=YOUR_API_KEY